| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10045810 | HBV | ENSG00000111424.12 | protein_coding | VDR | No | No | 7421 | P11473 |
| TVIS30006137 | HIV | ENSG00000111424.12 | protein_coding | VDR | No | No | 7421 | P11473 |
| TVIS30019074 | HIV | ENSG00000111424.12 | protein_coding | VDR | No | No | 7421 | P11473 |
| TVIS30077286 | HIV | ENSG00000111424.12 | protein_coding | VDR | No | No | 7421 | P11473 |
| TVIS30079341 | HIV | ENSG00000111424.12 | protein_coding | VDR | No | No | 7421 | P11473 |
| TVIS20045047 | HPV | ENSG00000111424.12 | protein_coding | VDR | No | No | 7421 | P11473 |
| TVIS44017496 | HTLV-1 | ENSG00000111424.12 | protein_coding | VDR | No | No | 7421 | P11473 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | VDR |
|---|---|
| DrugBank ID | DB04540 |
| Drug Name | Cholesterol |
| Target ID | BE0000779 |
| UniProt ID | P11473 |
| Regulation Type | |
| PubMed IDs | 16051528 |
| Citations | Mooijaart SP, Brandt BW, Baldal EA, Pijpe J, Kuningas M, Beekman M, Zwaan BJ, Slagboom PE, Westendorp RG, van Heemst D: C. elegans DAF-12, Nuclear Hormone Receptors and human longevity and disease at old age. Ageing Res Rev. 2005 Aug;4(3):351-71. |
| Groups | Approved; Investigational |
| Direct Classification | Cholesterols and derivatives |
| SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C |
| Pathways | Cerivastatin Action Pathway; 3-beta-Hydroxysteroid Dehydrogenase Deficiency; Pamidronate Action Pathway; Ibandronate Action Pathway; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH; Zellweger Syndrome; Lysosomal Acid Lipase Deficiency (Wolman Disease); Steroid Biosynthesis; Hypercholesterolemia; Risedronate Action Pathway; Mevalonic Aciduria; Congenital Bile Acid Synthesis Defect Type II; Apparent Mineralocorticoid Excess Syndrome; Rosuvastatin Action Pathway; Alendronate Action Pathway; Zoledronate Action Pathway; 11-beta-Hydroxylase Deficiency (CYP11B1); Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency; Cholesteryl Ester Storage Disease; Lovastatin Action Pathway; Bile Acid Biosynthesis; Corticosterone Methyl Oxidase I Deficiency (CMO I); 27-Hydroxylase Deficiency; Steroidogenesis; Fluvastatin Action Pathway; Atorvastatin Action Pathway; Pravastatin Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL112570 |
